DOSSIER · 13F-HR · Q1 2026

Palo Alto Investors LP

$654M in tracked AUM across 51 positions as of Q1 2026.

PA
CIK 0001306923 · last filed Mar 31, 2026
Total AUM
$654M
as of Q1 2026
Holdings
51
positions
Whale Score
64
64
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026
Comprehensive Analysis of Palo Alto Investors LP (SEC 13F) – Q3 2025
1. Portfolio Overview

Palo Alto Investors LP manages a concentrated, high-conviction portfolio characterized by a significant reduction in size and a pivot towards specific healthcare sub-sectors. As of the report date September 30, 2025, the total portfolio value stands at approximately $341.95 million, representing a sharp decrease of 27.2% from the previous quarter's $470.00 million.

The portfolio is highly concentra...

2. Key Holdings

The portfolio exhibits a "barbell" structure where a handful of top positions account for a significant portion of the total assets. The top five holdings comprise a massive 52.53% of the total portfolio value.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
INSM
INSMED INC
$68M415K10.4%
02
ACAD
ACADIA PHARMACEUTICALS INC
$64M2.9M9.8%
03
PTCT
PTC THERAPEUTICS INC
$63M922K9.6%
04
BMRN
BIOMARIN PHARMACEUTICAL INC
$39M685K5.9%
05
UTHR
UNITED THERAPEUTICS CORP
$37M63K5.7%
06
ANAB
ANAPTYSBIO INC
$35M638K5.4%
07
MIRM
MIRUM PHARMACEUTICALS INC
$30M325K4.6%
08
DYN
DYNE THERAPEUTICS INC
$30M1.7M4.6%
09
BIIB
BIOGEN INC
$26M141K3.9%
10
IRON
DISC MEDICINE INC
$26M402K3.9%

Filing history

2026Q1Mar 31
$654M 9.0%
51 positionsView →
2025Q4Dec 31
$718M 110.1%
49 positionsView →
2025Q3Sep 30
$342M 27.2%
31 positionsView →
2025Q2Jun 30
$470M 40.2%
45 positionsLocked
2025Q1Mar 31
$335M 48.0%
31 positionsLocked
2024Q4Dec 31
$645M 16.2%
43 positionsLocked
2024Q3Sep 30
$770M 10.8%
45 positionsLocked
2024Q2Jun 30
$863M 2.7%
39 positionsLocked
2024Q1Mar 31
$887M 20.1%
38 positionsLocked
2023Q4Dec 31
$1.1B 5.0%
34 positionsLocked
2023Q3Sep 30
$1.1B 14.6%
29 positionsLocked
2023Q2Jun 30
$1.2B 2.5%
30 positionsLocked
Showing 12 of 75